Why the study?
To further explore the cotton rat model by investigating the protective potential of a single intramuscular immunization and prime/boost immunizations with a low amount of influenza antigen.
Does a single or prime/boost intramuscular immunization with low-dose whole inactivated virus influenza vaccine improve humoral immune responses and protection from infection in cotton rats?
Does a single or prime/boost intramuscular immunization with low-dose whole inactivated virus influenza vaccine improve humoral immune responses and protection from infection in cotton rats?
In a cotton rat model, low-dose single and prime/boost influenza vaccination regimens can mimic partial and complete protection, providing a useful model for studying vaccine efficacy.
Answers are grounded in this paper and cite their sources.
Offers cotton rat model for low-dose WIV testing; leaves open human translation.
INTRODUCTION: Cotton rats are a suitable model for the study of influenza disease symptoms and responses to influenza vaccination. We have previously shown that two immunizations with 15 µg whole inactivated virus (WIV) influenza vaccine could completely protect animals from infection with the H1N1pdm09 virus. METHODS: To further explore the cotton rat model, we here investigated the protective potential of a single intramuscular immunization and of prime/boost intramuscular immunizations with a low amount of antigen. RESULTS: A single intramuscular immunization with doses more than or equal to 0.5 µg WIV reliably evoked antibody responses and doses more than or equal to 1 µg protected the animals from virus replication in the lungs and from severe weight loss. However, clinical symptoms like an increased respiration rate were still apparent. Administration of a booster dose significantly increased the humoral immune responses but did not or only moderately improved protection from clinical symptoms. CONCLUSION: Our data suggest that complete and partial protection by influenza vaccines can be mimicked in cotton rats by using specific vaccination regimens.
No takes yet. Share an insight, caveat, or question.
Bhide et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: